Patents

US 8835382 B2: Lipopeptide compositions and related methods

Granted
2014-09-16
Filed
2010-11-23 application 13511246
Type
Utility · 18 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. Some examples of the compositions comprise daptomycin and sucrose.

Source: PVGPATDIS, file of 2026-04-10 (ipg140916.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Cubist Pharmaceuticals LLC 29 patentsForeign company or organizationLexington, MACUBIST PHARMACEUTICALS INC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Sandra O'ConnorHudson, NH4PVGPATDIS, file of 2026-04-10
Sophie SunLexington, MA3PVGPATDIS, file of 2026-04-10
Gaauri NaikCambridge, MA3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K47/26PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P17/00PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K11/02PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-09-14Name change
Change of address
CUBIST PHARMACEUTICALS LLC signed 2016-07-14CUBIST PHARMACEUTICALS LLC 6000 LUCERNE 640026/743PASDL, file of 2026-10-15
2015-08-14Correction
Corrective assignment to correct the nature of conveyance previously recorded at reel: 036308 frame: 0207. assignor(s) hereby confirms the release of security interest.
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT signed 2015-07-07CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA
ADOLOR CORPORATION EXTON, PA
CALIXA THERAPEUTICS, INC. LEXINGTON, MA
36355/184PASDL, file of 2026-10-15
2015-08-12Security interest Security interest
Security interest
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT signed 2015-07-07CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA
ADOLOR CORPORATION EXTON, PA
CALIXA THERAPEUTICS, INC. LEXINGTON, MA
36308/207PASDL, file of 2026-10-15
2015-08-05Name change
Change of name
CUBIST PHARMACEUTICALS, INC. signed 2015-06-29CUBIST PHARMACEUTICALS LLC KENILWORTH, NJ36283/189PASDL, file of 2026-10-15
2012-11-20Security interest Security interest
Security agreement
CUBIST PHARMACEUTICALS, INC. signed 2012-11-20
ADOLOR CORPORATION signed 2012-11-20
CALIXA THERAPEUTICS, INC. signed 2012-11-20
CUBIST PHARMACEUTICALS HOLDINGS, INC. signed 2012-11-20
CUBIST PHARMACEUTICALS U.S. signed 2012-11-20
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT TORONTO, ONTARIO29339/669PASDL, file of 2026-10-15
2012-09-05Assignment
Assignment of assignor's interest
NAIK, GAAURI signed 2012-05-16
SUN, SOPHIE signed 2012-05-16
CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA28901/680ECORSEXC, file of 2026-09-25
2012-09-05Assignment
Assignment of assignor's interest
O'CONNOR, SANDRA signed 2012-08-22CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA28901/654ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.